Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $1.62 Million - $1.79 Million
14,800 New
14,800 $1.68 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $328,984 - $380,902
3,400 Added 125.93%
6,100 $590,000
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $561,385 - $678,535
-5,500 Reduced 67.07%
2,700 $293,000
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $934,964 - $1.14 Million
8,200 New
8,200 $971,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.